Adi Sarana Armada Tbk vs Merck Tbk. — how do they compare? Adi Sarana Armada Tbk trades at Rp605 (market cap 2.16T, 5.69M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Adi Sarana Armada Tbk is the larger of the two by market cap, and Adi Sarana Armada Tbk is more actively traded (5.69M versus 22.8K). Which is the better fit depends on your goals.
| ASSA | MERK | |
|---|---|---|
Market Cap | 2.16T | 1.68T |
Volume | 5.69M | 22.8K |
Lot | 56.9K | 228 |
Turnover | 3.39B | 82.9M |
Average Price | 595.99 | 3,636.14 |
Value | 3.39B | 82.9M |
Indicative Equilibrium Price | 605 | 3,520 |
Indicative Equilibrium Volume | 3.21K | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Adi Sarana Armada (the Company) was established in the Republic of Indonesia on December 17, 1999 based on the Notarial Deed no.56 of Misahardi Wilamarta, S.H. The Company's Articles of Association have been amended several times, the latest of which was covered by Notarial Deed no.11 of Liliek Zaenah, S.H., dated June 26, 2012, about the change in the Company's shareholders.
Read more on ASSA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →